Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Price:
4.81 CNY
Market Closed
Updated:
May 16, 2024
Northeast Pharmaceutical Group Co Ltd
Cost of Revenue
|
Northeast Pharmaceutical Group Co Ltd
Cost of Revenue Peer Comparison
Comparables:
H
3692
600436
600276
000538
S
688506
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
|
Cost of Revenue
-¥5.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cost of Revenue
-¥1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cost of Revenue
-¥5.7B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-24%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cost of Revenue
-¥3.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-11%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cost of Revenue
-¥28.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Cost of Revenue
-¥242.3m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Northeast Pharmaceutical Group Co Ltd's Cost of Revenue?
Cost of Revenue
-5.1B
CNY
-5.1B
CNY
Based on the financial report for Dec 31, 2023, Northeast Pharmaceutical Group Co Ltd's Cost of Revenue amounts to -5.1B CNY.
What is Northeast Pharmaceutical Group Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-6%
-6%
Over the last year, the Cost of Revenue growth was 8%. The average annual Cost of Revenue growth rates for Northeast Pharmaceutical Group Co Ltd have been -4% over the past three years , -3% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
